These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 33462533)

  • 21. Structural basis of inhibition of Mycobacterium tuberculosis DprE1 by benzothiazinone inhibitors.
    Batt SM; Jabeen T; Bhowruth V; Quill L; Lund PA; Eggeling L; Alderwick LJ; Fütterer K; Besra GS
    Proc Natl Acad Sci U S A; 2012 Jul; 109(28):11354-9. PubMed ID: 22733761
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of a new series of benzothiazinone derivatives with excellent antitubercular activity and improved pharmacokinetic profiles.
    Xiong L; Gao C; Shi YJ; Tao X; Rong J; Liu KL; Peng CT; Wang NY; Lei Q; Zhang YW; Yu LT; Wei YQ
    RSC Adv; 2018 Mar; 8(20):11163-11176. PubMed ID: 35541526
    [TBL] [Abstract][Full Text] [Related]  

  • 23. BTZ-Derived Benzisothiazolinones with In Vitro Activity against
    Richter A; Seidel RW; Goddard R; Eckhardt T; Lehmann C; Dörner J; Siersleben F; Sondermann T; Mann L; Patzer M; Jäger C; Reiling N; Imming P
    ACS Med Chem Lett; 2022 Aug; 13(8):1302-1310. PubMed ID: 35982823
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bioevaluation of quinoline-4-carbonyl derivatives of piperazinyl-benzothiazinones as promising antimycobacterial agents.
    Sahoo SK; Gajula SNR; Ahmad MN; Kaul G; Nanduri S; Sonti R; Dasgupta A; Chopra S; Yaddanapudi VM
    Arch Pharm (Weinheim); 2022 Nov; 355(11):e2200168. PubMed ID: 35876343
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New Insight into Dearomatization and Decarbonylation of Antitubercular 4H-Benzo[e][1,3]thiazinones: Stable 5H- and 7H-Benzo[e][1,3]thiazines.
    Richter A; Seidel RW; Graf J; Goddard R; Lehmann C; Schlegel T; Khater N; Imming P
    ChemMedChem; 2022 Mar; 17(6):e202200021. PubMed ID: 35170242
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and evaluation of triazole congeners of nitro-benzothiazinones potentially active against drug resistant
    Sahoo SK; Ahmad MN; Kaul G; Nanduri S; Dasgupta A; Chopra S; Yaddanapudi VM
    RSC Med Chem; 2022 May; 13(5):585-593. PubMed ID: 35694687
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of benzothiazones containing a hexahydropyrrolo[3,4-
    Ma X; Han B; Wang A; Yang L; Huang M; Chowdhury K; Gu J; Zhang K; Lv K
    RSC Adv; 2020 Apr; 10(24):14410-14414. PubMed ID: 35498504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An insight into the discovery, clinical studies, compositions, and patents of macozinone: A drug targeting the DprE1 enzyme of Mycobacterium tuberculosis.
    Imran M; Khan SA; Asdaq SMB; Almehmadi M; Abdulaziz O; Kamal M; Alshammari MK; Alsubaihi LI; Hussain KH; Alharbi AS; Alzahrani AK
    J Infect Public Health; 2022 Oct; 15(10):1097-1107. PubMed ID: 36122509
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fluorescent Benzothiazinone Analogues Efficiently and Selectively Label Dpre1 in Mycobacteria and Actinobacteria.
    Sommer R; Neres J; Piton J; Dhar N; van der Sar A; Mukherjee R; Laroche T; Dyson PJ; McKinney JD; Bitter W; Makarov V; Cole ST
    ACS Chem Biol; 2018 Nov; 13(11):3184-3192. PubMed ID: 30289689
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thiolates chemically induce redox activation of BTZ043 and related potent nitroaromatic anti-tuberculosis agents.
    Tiwari R; Moraski GC; Krchňák V; Miller PA; Colon-Martinez M; Herrero E; Oliver AG; Miller MJ
    J Am Chem Soc; 2013 Mar; 135(9):3539-49. PubMed ID: 23402278
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of Better Pharmacokinetic Benzothiazinone Derivatives as New Antitubercular Agents.
    Lv K; You X; Wang B; Wei Z; Chai Y; Wang B; Wang A; Huang G; Liu M; Lu Y
    ACS Med Chem Lett; 2017 Jun; 8(6):636-641. PubMed ID: 28626525
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structural studies of Mycobacterium tuberculosis DprE1 interacting with its inhibitors.
    Piton J; Foo CS; Cole ST
    Drug Discov Today; 2017 Mar; 22(3):526-533. PubMed ID: 27666194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ethionamide and Prothionamide Based Coumarinyl-Thiazole Derivatives: Synthesis, Antitubercular Activity, Toxicity Investigations and Molecular Docking Studies.
    Imran M
    Pharm Chem J; 2022; 56(9):1215-1225. PubMed ID: 36531826
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 2,6-Disubstituted 7-(naphthalen-2-ylmethyl)-7H-purines as a new class of potent antitubercular agents inhibiting DprE1.
    Finger V; Kucera T; Kafkova R; Muckova L; Dolezal R; Kubes J; Novak M; Prchal L; Lakatos L; Andrs M; Hympanova M; Marek J; Kufa M; Spiwok V; Soukup O; Mezeiova E; Janousek J; Nevosadova L; Benkova M; Kitson RRA; Kratky M; Bősze S; Mikusova K; Hartkoorn R; Roh J; Korabecny J
    Eur J Med Chem; 2023 Oct; 258():115611. PubMed ID: 37421887
    [TBL] [Abstract][Full Text] [Related]  

  • 35. hERG optimizations of IMB1603, discovery of alternative benzothiazinones as new antitubercular agents.
    Lv K; Wang A; Tao Z; Fu L; Liu H; Wang B; Ma C; Wang H; Ma X; Han B; Wang A; Zhang K; Liu M; Lu Y
    Eur J Med Chem; 2019 Oct; 179():208-217. PubMed ID: 31254922
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and structure-activity relationships evaluation of benzothiazinone derivatives as potential anti-tubercular agents.
    Gao C; Ye TH; Wang NY; Zeng XX; Zhang LD; Xiong Y; You XY; Xia Y; Xu Y; Peng CT; Zuo WQ; Wei Y; Yu LT
    Bioorg Med Chem Lett; 2013 Sep; 23(17):4919-22. PubMed ID: 23886691
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of selective DprE1 inhibitors: Design, synthesis, crystal structure and antitubercular activity of benzothiazolylpyrimidine-5-carboxamides.
    Chikhale R; Menghani S; Babu R; Bansode R; Bhargavi G; Karodia N; Rajasekharan MV; Paradkar A; Khedekar P
    Eur J Med Chem; 2015; 96():30-46. PubMed ID: 25874329
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficient Synthesis of Benzothiazinone Analogues with Activity against Intracellular Mycobacterium tuberculosis.
    Richter A; Narula G; Rudolph I; Seidel RW; Wagner C; Av-Gay Y; Imming P
    ChemMedChem; 2022 Mar; 17(6):e202100733. PubMed ID: 34939744
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design and synthesis of benzofuran- and naphthalene-fused thiazinones as antimycobacterial agents.
    Keiff F; Jacques Dit Lapierre TJW; Bernal FA; Kloss F
    Arch Pharm (Weinheim); 2023 Nov; 356(11):e2300356. PubMed ID: 37667452
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of novel benzothiopyranone compounds against Mycobacterium tuberculosis through scaffold morphing from benzothiazinones.
    Li P; Wang B; Zhang X; Batt SM; Besra GS; Zhang T; Ma C; Zhang D; Lin Z; Li G; Huang H; Lu Y
    Eur J Med Chem; 2018 Dec; 160():157-170. PubMed ID: 30336450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.